11 Jun 2021 --- Attitudes to CBD are opening up as COVID-19 has brought mental health into greater focus. This is according to Trip’s co-founder Olivia Ferdi, who speaks to NutritionInsight following the UK-based start-up raising £3.5 million (US$5 million) in partnership with investors including Maria Raga, Depop CEO, and serial entrepreneur and investor Christian Angermayer.
The company is positioned as a cross-section of lifestyle, beauty and wellness that focuses on mental well-being.
“While this has been a tough year for everyone, the world is recognizing that mental health is intrinsic to good health. We see that the lines between health, nutrition and mental health are now blurred,” she says.
People will change the way they think of health and well-being to a holistic view, where mental health is a crucial part, she predicts.
The shift of focus to mental well-being is echoed by Innova Market Insights’ trend, “Mood: The Next Occasion,” which reveals that 44 percent of global consumers are focusing on their mental and emotional well-being.
Finding calm in uncertainty
Ferdi says that many consumers are experiencing CBD for the first time by using Trip products during this period of heightened uncertainty and anxiety.
“The main factor that seems to motivate our consumers is personal recommendations, whether online or in-real-life, where sharing experiences encourages others to also find their calm,” she notes.
“It’s really rewarding to help so many people find their calm in such a chaotic time,” Ferdi adds.
Shift to mood
As Ferdi points out, the COVID-19 pandemic has taken a toll on consumers’ mental health worldwide.
“Attitudes to CBD in the UK and Europe have opened up so quickly, definitely accelerated during the pandemic and its impact on stress and anxiety,” she notes.